ResMed

Yahoo Finance • 16 hours ago

Anesthesia and Respiratory Devices Global Markets Report 2025-2030, Profiles of Prominent Players - F. Hoffmann-La Roche, Koninklijke Philips, ResMed, Teleflex, GE Healthcare, and Medtronic

Company Logo Key market opportunities in anesthesia and respiratory devices include technological advancements, regulatory developments, and growing demand for patient monitoring, ventilators, and disposable products. Companies can levera... Full story

Yahoo Finance • 2 days ago

ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than that, you probably want to see it rise more than the market average. Unfortunately for shareholders, while the ResMed Inc.... Full story

Yahoo Finance • 9 days ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Health... Full story

Yahoo Finance • 11 days ago

Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock

[Stock Market Health Care Index. Trading screen with a sector index for Health Care, quotes, charts and changes.] Torsten Asmus The average short interest in the S&P 500 Healthcare sector (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV... Full story

Yahoo Finance • 15 days ago

ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. ResMed Inc. is placed fourth among them. ResMed Inc. (NYSE:RMD) is a leading health technology company focused on sleep, breathing, and home care s... Full story

Yahoo Finance • 15 days ago

Top S&P500 movers in Wednesday's session

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. [topmovers] TOP GAINERS TICKER CHANGE COMMENT ORCL [https://www.chartmill.com/stock/quote/ORCL/profile] 40.3% Investors c... Full story

Yahoo Finance • 16 days ago

These S&P500 stocks are gapping in today's session

Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT ORCL [https://www.... Full story

Yahoo Finance • 22 days ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global clinic... Full story

Yahoo Finance • 25 days ago

ResMed Inc. (NYSE:RMD): A Top Dividend Stock for Sustainable Income and Growth

When looking for reliable dividend-paying stocks, investors often use screening strategies that prioritize both income generation and fundamental stability. The approach typically involves identifying companies with strong dividend ratings... Full story

Yahoo Finance • 28 days ago

Thursday's ETF with Unusual Volume: MTRA

The Invesco International Growth Focus ETF is seeing unusually high volume in afternoon trading Thursday, with over 150,000 shares traded versus three month average volume of about 27,000. Shares of MTRA were up about 0.1% on the day. Co... Full story

Yahoo Finance • last month

ResMed stock hits 52-week high at 293.1 USD

ResMed Inc (NYSE:RMD). stock reached a 52-week high, trading at 293.1 USD, reflecting a strong performance over the past year. With a market capitalization of $42.9 billion, the company’s stock has delivered impressive returns, including... Full story

Yahoo Finance • last month

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue? Continue Reading View Comments... Full story

Yahoo Finance • last month

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare... Full story

Yahoo Finance • last month

[Latest] Global High Flow Nasal Cannula Market Size/Share Worth USD 5.9 Billion by 2034 at a 5.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global High Flow Nasal Cannula Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 2 months ago

ResMed Inc (NYSE:RMD): A Strong Dividend Stock with Growth Potential and Financial Stability

Dividend investing continues to be a key strategy for investors looking for steady income, especially in uncertain markets. One way to find strong dividend options is by looking for stocks with high dividend ratings and solid profitability... Full story

Yahoo Finance • 2 months ago

Ventilators Company Evaluation Report 2025 - ResMed, Getinge, and Philips Lead the Ventilator Market Through Innovation, Strong Global Presence, and Strategic Use of Technology and Partnerships

Company Logo The Ventilator Companies Quadrant offers an in-depth analysis of the global ventilators market, spotlighting top players like ResMed, Getinge AB, and Koninklijke Philips N.V. This report highlights technological advancements... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: ResMed's Q4 2025 shows strong EPS, stock dips post-call

ResMed Inc. (RMD) reported its fourth-quarter earnings for fiscal year 2025, surpassing earnings per share (EPS) expectations but falling short on revenue forecasts. The company achieved an EPS of $2.55, exceeding the forecast of $2.48, wh... Full story

Yahoo Finance • 2 months ago

Resmed Australia shares hit record high on strong earnings

Investing.com--  Australian shares of Resmed (NYSE:RMD) Inc DRC (ASX:RMD) hit a record high on Friday after the medical devices maker clocked stronger than expected June quarter earnings. Resmed’s shares rose as much as 3% to a record hig... Full story

Yahoo Finance • 2 months ago

Resmed Inc. (NYSE:RMD) Beats Q4 2025 Revenue and EPS Estimates Despite Muted Market Reaction

RESMED INC. (NYSE:RMD [https://www.chartmill.com/stock/quote/RMD/profile]) REPORTS Q4 2025 EARNINGS: REVENUE AND EPS BEAT ESTIMATES, MARKET REACTION MUTED Resmed Inc. (NYSE:RMD [https://www.chartmill.com/stock/quote/RMD/profile]) released... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Trump’s tariff threats, J&J, Abbott Laboratories and Sarepta in focus

Just a day after the S&P 500 and Nasdaq climbed into record territory, U.S. stocks end mixed, with American Express (AXP [https://seekingalpha.com/symbol/AXP]) and 3M (MMM [https://seekingalpha.com/symbol/MMM]) dragging the Dow, and more t... Full story